APAC multiple myeloma market to value $2.8 bn by 2021: Report

Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...

October 23, 2015 | Friday | Analysis
India slashes prices of 54 essential drugs

Singapore: With a view to make medicines for critical diseases more affordable, India's National Pharmaceutical Pricing ...

May 12, 2016 | Thursday | News
Baxter erects global R&D center at Syngene

Bangalore: Baxter has constructed its R&D center at Biocon's Syngene facility. The facility, which was developed a...

February 5, 2014 | Wednesday | News
India's Biological E to buy French Valneva's CMO unit

Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-b...

June 11, 2013 | Tuesday | News
Lupin gets 16 FDA nods, launches 11 products front

US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FD...

June 4, 2013 | Tuesday | Analysis
FDA approves Sun Pharma's generic Prandin

Singapore: The US Food and Drug Administration (FDA) has given its finally approval to India's Sun Pharmaceutical Indust...

July 12, 2013 | Friday | Regulatory
Singapore's Fortis Surgical Hospital is now Concord Medical Services

Singapore: Concord Medical Services, China based hospital management solution provider, has received Singapore's approva...

October 16, 2015 | Friday | News
Cipla, Alembic contest Indian drug pricing in court

Singapore: Miffed at Indian government's move to slash prices of essential medicines through the new drug pricing policy...

July 17, 2013 | Wednesday | News
India's AYUSH becomes popular in Asia

Singapore: With the ancient Indian medicine systems AYUSH (Ayurveda, Yoga, Unani, Siddha and Homeopathy) gaining popular...

July 22, 2015 | Wednesday | News
Quintiles and Biogen Idec ink pact

Singapore: Quintiles and US-based biotech company Biogen Idec have entered into a five-year strategic clinical developme...

May 5, 2014 | Monday | News
Biocon launches world's first Biosimilar 'CANMAb' in India

Bangalore: CANMAb has been jointly developed by Biocon in partnership with Mylan and it is said to be the world's first ...

January 20, 2014 | Monday | News
Piramal to acquire US-based Decision Resource Group

Mumbai: Piramal Healthcare, an innovation led company, has agreed to acquire Decision Resources Group (DRG) a US-based c...

May 17, 2012 | Thursday | News
Cadila Healthcare eyeing US, Europe markets

Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon sta...

September 15, 2014 | Monday | News
Indian drug dealers worried about $1.69 bn old stocks

New Delhi: Ahead of the Drug Price Control Order (DPCO) to revise drug prices that came into effect on July 29, medicine...

August 2, 2013 | Friday | News
Dr Reddy's launch cystic acne generic Zenatane

Hyderabad: Dr. Reddy's Laboratories launched Zenatane (isotretinoin) capsules in 20 mg and 40 mg in the US. The drug i...

April 2, 2013 | Tuesday | News
Transasia gets award from the President of India

New Delhi: Transasia BioMedicals, one of India's largest IVD companies, was recently conferred with the coveted 'Niryat ...

October 26, 2012 | Friday | News
FIPB approves investments worth $143.43 mn

Singapore: The Foreign Investment Promotion Board (FIPB) in India cleared six investment proposals in the pharmaceutical...

July 30, 2013 | Tuesday | News
Dr. Reddy's generic of Revatio (sildenafil) now available in US

Hyderabad: Dr. Reddy's Laboratories has launched sildenafil tablets (20 mg), a bioequivalent generic version of Revatio...

November 20, 2012 | Tuesday | News